FIC20230004I1 - Melfalaaniflufenamidihydrokloridi - Google Patents

Melfalaaniflufenamidihydrokloridi

Info

Publication number: FIC20230004I1
Authority: FI; Finland
Prior art keywords: melphalan flufenamide; flufenamide hydrochloride; hydrochloride; melphalan; flufenamide
Prior art date: 2011-04-28

Application number

FIC20230004C

Other languages

English (en)

Original Assignee

Oncopeptides Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-04-28

Filing date

2023-01-19

Publication date

2023-01-19

2023-01-19 Application filed by Oncopeptides Ab filed Critical Oncopeptides Ab

2023-01-19 Publication of FIC20230004I1 publication Critical patent/FIC20230004I1/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A61K38/105—Bombesin; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Biochemistry (AREA)
Mechanical Engineering (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

FIC20230004C 2011-04-28 2023-01-19 Melfalaaniflufenamidihydrokloridi FIC20230004I1 (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE1150371		2011-04-28

Publications (1)

Publication Number	Publication Date
FIC20230004I1 true FIC20230004I1 (fi)	2023-01-19

Family

ID=47071620

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FIC20230004C FIC20230004I1 (fi)	2011-04-28	2023-01-19	Melfalaaniflufenamidihydrokloridi

Country Status (29)

Country	Link
US (8)	US20140128462A1 (fi)
EP (4)	EP2701720B1 (fi)
JP (1)	JP6042412B2 (fi)
KR (2)	KR101808895B1 (fi)
CN (2)	CN108096563A (fi)
AU (1)	AU2012247545B2 (fi)
BR (2)	BR112013027584B1 (fi)
CA (2)	CA2833500C (fi)
CY (2)	CY1119453T1 (fi)
DK (3)	DK3228319T3 (fi)
ES (2)	ES2642676T3 (fi)
FI (1)	FIC20230004I1 (fi)
FR (1)	FR23C1000I2 (fi)
HR (2)	HRP20221355T1 (fi)
HU (3)	HUE060783T2 (fi)
IL (3)	IL228889A0 (fi)
LT (2)	LT3656393T (fi)
LU (1)	LUC00291I2 (fi)
MX (1)	MX345102B (fi)
NL (1)	NL301206I2 (fi)
NO (1)	NO2023004I1 (fi)
PL (3)	PL2701720T3 (fi)
PT (2)	PT2701720T (fi)
RS (3)	RS63747B1 (fi)
RU (1)	RU2597154C2 (fi)
SI (2)	SI2701720T1 (fi)
SM (3)	SMT202000447T1 (fi)
WO (1)	WO2012146625A1 (fi)
ZA (1)	ZA201308765B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LT3656393T (lt)	2011-04-28	2022-12-12	Oncopeptides Ab	Liofilizuoti citotoksinių dipeptidų preparatai
JP5827178B2 (ja) *	2012-06-05	2015-12-02	北越紀州製紙株式会社	セルロース多孔質体及びその製造方法
EP3628318A1 (en) *	2012-10-26	2020-04-01	Oncopeptides AB	Lyophilized preparations of melphalan flufenamide
ES2768268T3 (es) *	2012-10-26	2020-06-22	Oncopeptides Ab	Preparaciones liofilizadas de melfalán flufenamida
GB201507903D0 (en)	2015-05-08	2015-06-24	Oncopeptides Ab	Process for preparation of nitrogen mustard derivatives
GB201521217D0 (en)	2015-12-01	2016-01-13	Oncopeptides Ab	Dosage regimens
US10507165B2 (en)	2017-05-31	2019-12-17	Adienne Pharma & Biotech Sa	Multi chamber flexible bag and methods of using same
US10369077B2 (en) *	2017-05-31	2019-08-06	Adienne Pharma & Biotech Sa	Multi chamber flexible bag and methods of using the same
ES2942468T3 (es) *	2018-10-18	2023-06-01	Oncopeptides Ab	Compuestos que contienen deuterio
WO2020201542A1 (en)	2019-04-03	2020-10-08	Oncopeptides Ab	Treatment of al amyloidosis with melflufen
GB201905477D0 (en) *	2019-04-17	2019-05-29	Oncopeptides Ab	Novel formulations
WO2021053185A1 (en)	2019-09-20	2021-03-25	Oncopeptides Ab	Melflufen formulations and their use in the treatment or prophylaxis of osteosarcoma
US11503829B2 (en) *	2020-05-08	2022-11-22	Gjb Applied Technologies, Inc.	Pesticidal compositions and related methods
US12077809B2 (en)	2021-04-27	2024-09-03	Enplas Corporation	Freeze-dried structure and producing method thereof
WO2023281007A1 (en)	2021-07-08	2023-01-12	Oncopeptides Ab	Melflufen for use in the treatment of multiple myeloma
GB202109894D0 (en)	2021-07-08	2021-08-25	Oncopeptides Ab	Novel treatments
GB202109896D0 (en)	2021-07-08	2021-08-25	Oncopeptides Ab	Novel treatments
GB202109895D0 (en)	2021-07-08	2021-08-25	Oncopeptides Ab	Novel treatments
KR102757193B1 (ko) *	2021-10-19	2025-01-21	단국대학교 천안캠퍼스 산학협력단	피리미딘-2,4-다이온 유도체를 유효성분으로 포함하는 근감소증의 예방 또는 치료용 조성물
GB202204171D0 (en)	2022-03-24	2022-05-11	Oncopeptides Ab	Novel formulations

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB750155A (en)	1953-03-17	1956-06-13	Nat Res Dev	Substituted alanines
GB8727157D0 (en) *	1987-11-19	1987-12-23	Wellcome Found	Pharmaceutical formulations
JP3176716B2 (ja)	1991-06-21	2001-06-18	武田薬品工業株式会社	溶解性が向上した難水溶性薬物組成物
US5595756A (en) *	1993-12-22	1997-01-21	Inex Pharmaceuticals Corporation	Liposomal compositions for enhanced retention of bioactive agents
SE0002202D0 (sv) *	2000-06-13	2000-06-13	Karolinska Innovations Ab	New peptides
DE60141398D1 (de) *	2000-06-13	2010-04-08	Oncopeptides Ab	Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs
JP2005508220A (ja)	2001-10-24	2005-03-31	パーリ・ゲーエムベーハー	薬用組成物調製用具
AR038535A1 (es) *	2002-02-22	2005-01-19	Schering Corp	Formulaciones farmaceuticas de agentes antineoplasicos y procesos para prepararlos y usarlos
US6780324B2 (en) *	2002-03-18	2004-08-24	Labopharm, Inc.	Preparation of sterile stabilized nanodispersions
US7323479B2 (en)	2002-05-17	2008-01-29	Celgene Corporation	Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
US20040034099A1 (en) *	2002-06-27	2004-02-19	Ramsey Beverly J.	Pharmaceutical composition
US20050152979A1 (en) *	2003-09-05	2005-07-14	Cell Therapeutics, Inc.	Hydrophobic drug compositions containing reconstitution enhancer
BRPI0513332A (pt)	2004-08-12	2008-05-06	Schering Corp	formulação de interferon peguilado estável
DK1658848T3 (da) *	2004-10-29	2007-11-26	Pharma Mar Sa	Formuleringer omfattende ecteinascidin og et disaccharid
EP1674098A1 (en)	2004-12-23	2006-06-28	Schering Aktiengesellschaft	Stable and tolerable parental formulations of highly reactive organic drug substances with low or no solubility in water
GB0522082D0 (en) *	2005-10-31	2005-12-07	Pharma Mar Sa	Formulations
AU2007269614B2 (en)	2006-07-07	2011-09-08	Gilead Sciences, Inc.	Novel pyridazine compound and use thereof
CA2669913C (en)	2006-11-21	2012-09-18	Jina Pharmaceuticals, Inc.	Endoxifen methods and compositions
CN101584669B (zh) *	2009-06-19	2010-12-29	江苏奥赛康药业有限公司	美法仑冻干粉针剂
WO2011078782A1 (en) *	2009-12-22	2011-06-30	Oncopeptides Ab	A composition comprising of melphalan derivatives and gemcitabine or etoposide useful in the treatment of cancer
AR077384A1 (es)	2010-07-05	2011-08-24	Eriochem Sa	Una formulacion farmaceutica inyectable de melfalano.
BR112013026363B1 (pt) *	2011-04-15	2021-10-13	Janssen Pharmaceutica Nv	Nanossuspensões compreendendo 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil] amino] benzonitrila, seu processo de preparação e composição farmacêutica para administração por injeção intramuscular ou subcutânea
LT3656393T (lt)	2011-04-28	2022-12-12	Oncopeptides Ab	Liofilizuoti citotoksinių dipeptidų preparatai
EP3628318A1 (en)	2012-10-26	2020-04-01	Oncopeptides AB	Lyophilized preparations of melphalan flufenamide

2012
- 2012-04-25 LT LTEP19215699.0T patent/LT3656393T/lt unknown
- 2012-04-25 HU HUE19215699A patent/HUE060783T2/hu unknown
- 2012-04-25 EP EP12718949.6A patent/EP2701720B1/en active Active
- 2012-04-25 SI SI201231086T patent/SI2701720T1/sl unknown
- 2012-04-25 CN CN201810054866.9A patent/CN108096563A/zh active Pending
- 2012-04-25 HR HRP20221355TT patent/HRP20221355T1/hr unknown
- 2012-04-25 DK DK17173249.8T patent/DK3228319T3/da active
- 2012-04-25 AU AU2012247545A patent/AU2012247545B2/en active Active
- 2012-04-25 KR KR1020137031096A patent/KR101808895B1/ko active Active
- 2012-04-25 EP EP17173249.8A patent/EP3228319B1/en active Active
- 2012-04-25 RU RU2013152751/15A patent/RU2597154C2/ru active
- 2012-04-25 PL PL12718949T patent/PL2701720T3/pl unknown
- 2012-04-25 BR BR112013027584-7A patent/BR112013027584B1/pt active IP Right Grant
- 2012-04-25 CA CA2833500A patent/CA2833500C/en active Active
- 2012-04-25 SM SM20200447T patent/SMT202000447T1/it unknown
- 2012-04-25 CA CA3024230A patent/CA3024230C/en active Active
- 2012-04-25 JP JP2014506850A patent/JP6042412B2/ja active Active
- 2012-04-25 EP EP19215699.0A patent/EP3656393B1/en active Active
- 2012-04-25 BR BR122019017088-6A patent/BR122019017088B1/pt active IP Right Grant
- 2012-04-25 SI SI201231829T patent/SI3228319T1/sl unknown
- 2012-04-25 DK DK12718949.6T patent/DK2701720T3/en active
- 2012-04-25 CN CN201280019920.7A patent/CN103547279A/zh active Pending
- 2012-04-25 US US14/113,768 patent/US20140128462A1/en not_active Abandoned
- 2012-04-25 MX MX2013012545A patent/MX345102B/es active IP Right Grant
- 2012-04-25 ES ES12718949.6T patent/ES2642676T3/es active Active
- 2012-04-25 PT PT127189496T patent/PT2701720T/pt unknown
- 2012-04-25 PL PL19215699.0T patent/PL3656393T3/pl unknown
- 2012-04-25 EP EP22191185.2A patent/EP4122482A1/en active Pending
- 2012-04-25 ES ES19215699T patent/ES2930140T3/es active Active
- 2012-04-25 SM SM20170459T patent/SMT201700459T1/it unknown
- 2012-04-25 RS RS20221059A patent/RS63747B1/sr unknown
- 2012-04-25 RS RS20201030A patent/RS60719B1/sr unknown
- 2012-04-25 HU HUE12718949A patent/HUE037863T2/hu unknown
- 2012-04-25 PL PL17173249T patent/PL3228319T3/pl unknown
- 2012-04-25 RS RS20171002A patent/RS56462B1/sr unknown
- 2012-04-25 KR KR1020177035122A patent/KR102122416B1/ko active Active
- 2012-04-25 SM SM20220450T patent/SMT202200450T1/it unknown
- 2012-04-25 DK DK19215699.0T patent/DK3656393T3/da active
- 2012-04-25 HR HRP20171523TT patent/HRP20171523T1/hr unknown
- 2012-04-25 PT PT192156990T patent/PT3656393T/pt unknown
- 2012-04-25 LT LTEP12718949.6T patent/LT2701720T/lt unknown
- 2012-04-25 WO PCT/EP2012/057577 patent/WO2012146625A1/en active Application Filing
2013
- 2013-10-15 IL IL228889A patent/IL228889A0/en active IP Right Grant
- 2013-11-21 ZA ZA2013/08765A patent/ZA201308765B/en unknown
2016
- 2016-08-01 US US15/225,323 patent/US10322182B2/en active Active
2017
- 2017-10-12 CY CY20171101070T patent/CY1119453T1/el unknown
2019
- 2019-03-19 IL IL265457A patent/IL265457B/en active IP Right Grant
- 2019-04-12 US US16/382,276 patent/US10543274B2/en active Active
- 2019-06-28 US US16/457,102 patent/US20200009252A1/en not_active Abandoned
- 2019-12-19 US US16/721,639 patent/US10869928B2/en active Active
2020
- 2020-02-03 IL IL272429A patent/IL272429B/en unknown
- 2020-07-22 US US16/935,372 patent/US11344622B2/en active Active
- 2020-08-12 CY CY20201100749T patent/CY1123242T1/el unknown
2022
- 2022-04-27 US US17/730,398 patent/US11896668B2/en active Active
- 2022-12-13 NL NL301206C patent/NL301206I2/nl unknown
- 2022-12-13 LU LU00291C patent/LUC00291I2/fr unknown
2023
- 2023-01-04 FR FR23C1000C patent/FR23C1000I2/fr active Active
- 2023-01-16 NO NO2023004C patent/NO2023004I1/no unknown
- 2023-01-16 HU HUS2300005C patent/HUS2300005I1/hu unknown
- 2023-01-19 FI FIC20230004C patent/FIC20230004I1/fi unknown
2024
- 2024-07-19 US US18/400,055 patent/US20240358838A1/en active Pending

Also Published As

Publication number	Publication date
IL272429B (en)	2022-05-01
RU2597154C2 (ru)	2016-09-10
PL3656393T3 (pl)	2023-01-16
EP3656393B1 (en)	2022-08-24
JP6042412B2 (ja)	2016-12-14
US20170049894A1 (en)	2017-02-23
US10543274B2 (en)	2020-01-28
KR20170140409A (ko)	2017-12-20
HUS2300005I1 (hu)	2023-02-28
IL265457B (en)	2021-02-28
US10869928B2 (en)	2020-12-22
HUE037863T2 (hu)	2018-09-28
IL272429A (en)	2020-03-31
HUE060783T2 (hu)	2023-04-28
DK3228319T3 (da)	2020-09-07
EP2701720A1 (en)	2014-03-05
NZ617197A (en)	2015-06-26
US20220323585A1 (en)	2022-10-13
US20200009252A1 (en)	2020-01-09
CA3024230A1 (en)	2012-11-01
US20140128462A1 (en)	2014-05-08
HRP20221355T1 (hr)	2022-12-23
RU2013152751A (ru)	2015-06-10
CY1123242T1 (el)	2021-10-29
EP2701720B1 (en)	2017-07-12
RS63747B1 (sr)	2022-12-30
WO2012146625A1 (en)	2012-11-01
CN103547279A (zh)	2014-01-29
RS56462B1 (sr)	2018-01-31
BR112013027584B1 (pt)	2020-11-03
LT2701720T (lt)	2017-11-10
NL301206I1 (en)	2022-12-14
US10322182B2 (en)	2019-06-18
CA2833500A1 (en)	2012-11-01
US11344622B2 (en)	2022-05-31
SI3228319T1 (sl)	2020-10-30
US11896668B2 (en)	2024-02-13
NO2023004I1 (no)	2023-01-16
ZA201308765B (en)	2016-02-24
JP2014512402A (ja)	2014-05-22
ES2642676T3 (es)	2017-11-17
US20190240332A1 (en)	2019-08-08
SI2701720T1 (sl)	2017-11-30
NL301206I2 (nl)	2023-01-24
BR112013027584A2 (pt)	2016-09-06
RS60719B1 (sr)	2020-09-30
FR23C1000I2 (fr)	2024-03-15
PL2701720T3 (pl)	2017-12-29
KR20140041497A (ko)	2014-04-04
PT3656393T (pt)	2022-11-03
AU2012247545B2 (en)	2016-08-11
MX2013012545A (es)	2014-04-16
PT2701720T (pt)	2017-10-20
US20200345848A1 (en)	2020-11-05
DK3656393T3 (da)	2022-11-14
US20240358838A1 (en)	2024-10-31
MX345102B (es)	2017-01-16
CA2833500C (en)	2019-01-08
SMT202000447T1 (it)	2020-09-10
CN108096563A (zh)	2018-06-01
EP4122482A1 (en)	2023-01-25
PL3228319T3 (pl)	2021-02-08
HRP20171523T1 (hr)	2017-11-17
EP3228319A1 (en)	2017-10-11
AU2012247545A1 (en)	2013-10-31
US20200121794A1 (en)	2020-04-23
DK2701720T3 (en)	2017-10-09
ES2930140T3 (es)	2022-12-07
IL265457A (en)	2019-05-30
KR102122416B1 (ko)	2020-06-12
SMT202200450T1 (it)	2023-01-13
CY1119453T1 (el)	2018-03-07
LUC00291I2 (fi)	2025-05-12
SMT201700459T1 (it)	2017-11-15
EP3656393A1 (en)	2020-05-27
LT3656393T (lt)	2022-12-12
BR122019017088B1 (pt)	2021-11-16
IL228889A0 (en)	2013-12-31
EP3228319B1 (en)	2020-06-03
CA3024230C (en)	2022-10-18
FR23C1000I1 (fr)	2023-03-10
KR101808895B1 (ko)	2017-12-13

Publication	Publication Date	Title
FIC20230004I1 (fi)	2023-01-19	Melfalaaniflufenamidihydrokloridi
NL301241I2 (nl)	2023-10-26	Belantamab mafodotin
NL301315I2 (nl)	2025-03-17	Flortaucipir
EP3656792C0 (en)	2024-07-03	FC IMMUNOGLOBULIN VARIANTS
EP2780065A4 (en)	2015-05-27	NASAL MASK SYSTEM
EP2768410A4 (en)	2015-09-02	EXTENSION COLLAR SYSTEM
CO6900146A2 (es)	2014-03-20	Imidazopiridazinas sustituidas con amino
DE102011100082A8 (de)	2013-01-10	Traygreifvorrichtung
BR112014000879A2 (pt)	2017-02-21	deflegmador
EP2795884A4 (en)	2015-07-29	Audio conferencing
CO6960543A2 (es)	2014-05-30	2-tiopirimidinonas
EP2705094A4 (en)	2015-09-23	COLORANTS DISULFURE
DK3141251T3 (da)	2021-02-01	Koloskopi - forberedelse
DE112011104936A5 (de)	2013-11-28	Stanzstauchniet
FI20116031A7 (fi)	2013-02-28	Patukkakotelo
DE112012000958A5 (de)	2013-11-28	Handsäge
DK2476953T3 (da)	2020-05-11	Fluidbedkedel
DE112012002458A5 (de)	2014-02-27	Hydrotransformator
DE112012000819A5 (de)	2013-11-14	Gurtbandfänger
UA23002S (uk)	2012-04-25	Ніж
FR2975867B1 (fr)	2014-05-02	Elagueuse
DE112012005313A5 (de)	2015-04-23	Leuchtbild
DK2526750T3 (da)	2014-05-26	Høbjærgningsmaskine
DE112012001294T8 (de)	2014-04-03	Umspritzungsverfahren
EP2692644A4 (en)	2014-09-24	SPACECRAFT